CAS RN: 956101-10-3
2-Chloro-7-fluoroquinazoline
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260223
100mg / 250mg / 1g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g, 0.25g, 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 956101-10-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
>97%
0
Out of Stock
Hong Kong
Inquiry
0.25g
>97%
0
Out of Stock
Shanghai
Inquiry
1g
>97%
0
Out of Stock
Shenzhen
Inquiry
956101-10-3 / 2-chloro-7-fluoroquinazoline
Standard CAS: 956101-10-3
Multi CAS: No
Basic Information
copy
CAS
956101-10-3 copy
Multi CAS
No copy
Molecular Formula
C8H4CLFN2 copy
Molecular Weight
182.580000 copy
Exact Mass
182.004704 copy
InChI
InChI=1S/C8H4ClFN2/c9-8-11-4-5-1-2-6(10)3-7(5)12-8/h1-4H copy
InChIKey
FRAVNDLHGCORAY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
2 copy
Molar refractivity
44.51 copy
TPSA
25.78 copy
LogP / Solubility
WLOGP
2.42 copy
MLOGP
2.13 copy
XLogP3
2.6 copy
Consensus LogP
2.38 copy
Log S (ESOL)
-3.11 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-2.81 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.86 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.11 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy